Table 2.
Criteria | Frequency | Percent |
---|---|---|
Stage of disease | ||
T1N0M0 | 11 | 2.8 |
T1N2M0 | 1 | 0.3 |
T2N0M0 | 28 | 7.2 |
T2N0M1 | 2 | 0.5 |
T2N1M0 | 11 | 2.8 |
T2N2M0 | 3 | 0.8 |
T3N0M0 | 58 | 14.9 |
T3N0M1 | 7 | 1.8 |
T3N1M0 | 68 | 17.5 |
T3N1M1 | 11 | 2.8 |
T3N2M0 | 52 | 13.4 |
T3N2M1 | 8 | 2.1 |
T3N3M1 | 1 | 0.3 |
T4N0M0 | 28 | 7.2 |
T4N0M1 | 1 | 0.3 |
T4N1M0 | 39 | 10.1 |
T4N1M1 | 2 | 0.5 |
T4N2M0 | 42 | 10.8 |
T4N2M1 | 13 | 3.4 |
T4N3M0 | 1 | 0.3 |
T4N3M1 | 1 | 0.3 |
Location of the tumor | ||
Lower | 153 | 39.4 |
Middle | 153 | 39.4 |
Upper | 82 | 21.1 |
Coexisting disease or pathology | ||
Present | 121 | 31.2 |
• DMa | 17 | 4.4 |
• DM+HTb | 13 | 3.4 |
• DM+CADc | 4 | 1.0 |
• DM+CAD+HT+Other | 1 | 0.3 |
• DM+COPDd | 1 | 0.3 |
• DM+COPD+HT | 1 | 0.3 |
• HT | 44 | 11.3 |
• HT+Other | 2 | 0.5 |
• HT+CKFe | 2 | 0.5 |
• CAD | 9 | 2.3 |
• CAD +HT | 3 | 0.8 |
• CKF | 4 | 1.0 |
• COPD | 12 | 3.1 |
•COPD+HT | 2 | 0.5 |
•COPD+CAD | 1 | 0.3 |
• CLFf | 1 | 0.3 |
• Other | 4 | 1.0 |
Absent | 267 | 68.8 |
Invasion of adjacent organs | ||
Present | 46 | 11.9 |
Absent | 342 | 88.1 |
Surgeon’s experience | ||
Lower than 20 | 43 | 11,1 |
Equal or upper than 20 | 345 | 88,9 |
Presence of perforation | ||
Present | 0 | 0 |
Absent | 388 | 100.0 |
Presence of obstruction | ||
Present | 0 | 0 |
Absent | 388 | 100.0 |
Presence of fistula | ||
Present | 0 | 0 |
Absent | 388 | 100.0 |
aDM: Diabetes mellitus;
bHT: Hypertension;
cCAD: Coronary artery disease;
dCOPD: Chronic obstructive pulmonary disease;
eCKF: Chronic kidney failure;
fCLF: Chronic liver failure